VOY-101

N/A

Report date: 2024/11/25 13:28:10

Base Information

Drug NameVOY-101
Drug Alias NameVOY-101
ClassificationBiologics
Mechanisms of ActionSerine protease HTRA1 modulators
TargetsSerine protease HTRA1
Therapy Area/IndicationsGeographic AtrophyMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaIsrael
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPerceive Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGeographic AtrophyMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A